EMPOWER YOUR LABORATORY WITH TOTAL VALUE OF OWNERSHIP

Watch the Webinar

Total Value Of Ownership


DO YOU KNOW THE TOTAL VALUE THAT LIES WITHIN AND BEYOND YOUR
LABORATORY WALLS?

ABSTRACT

In today’s healthcare environment, leaders are increasingly asked to demonstrate value in terms of operational and clinical care excellence across their healthcare institution. The clinical laboratory is viewed as an important contributor to key performance indicators, and as a result, laboratory managers want to maximize the value that the laboratory brings to their institutions.

The concept of Total Value of Ownership (TVO) considers all aspects of a laboratory’s processes and equipment and identifies areas where improvements can be made to maximize value. When the laboratory delivers services to its full potential, it can help improve outcomes system-wide, enabling the institution to make a positive impact on patient outcomes.

LEARNING OBJECTIVES

In this webinar, you will:

  • Learn about the Total Value of Ownership (TVO) and Total Cost of Ownership (TCO) methodologies,
  • Understand how you can apply these methodologies to improve your laboratory’s operational performance and maximize its value to the organization, and
  • Hear first-hand experiences, like: a TVO-based analysis conducted by Abbott for the Korea Clinical Laboratory, and a comparative TCO analysis of 5 leading analytical platforms, including the Alinity ci-series, performed by an independent laboratory.

Understand the total value of ownership

 
                 

 

Speaker Bios


Image of Patrick GontardPatrick Gontard  
Group CEO, Labexa Group, France; CEO and Founder, Gontard and Cie, Switzerland 





Patrick Gontard possesses more than 25 years of medical industry experience, in a variety of senior leadership roles across laboratories, hospitals, and professional medical associations. 
Known as a subject matter expert on the topic of Total Cost of Ownership (TCO), Mr. Gontard has developed and implemented a TCO model, which has been applied in laboratory settings to become an evidence based, real life management tool for calculating and controlling costs related to laboratory and hospital operational efficiency. 

Responsible for restructuring and management, including commercial and scientific leadership in various laboratories throughout Europe and the Middle East, Mr. Gontard's TCO methodology has helped to uncover and quantify hidden or indirect costs and deliver operational efficiencies and improvements in profitability. Patrick has perfected his Total Cost of Ownership model over the years, working for organizations such as Viollier the second largest Swiss laboratory group, Integrated Diagnostics in Egypt, Citilab the second largest laboratory group in Russia, and currently is the laboratory CEO at Exalab in France.

Image of Jose SantiagoPaul Clarke   
Director of Strategy,
Abbott Diagnostics 


 




Paul Clarke is the Strategy Director for Abbott Diagnostics, Asia Pacific. Paul has more than 20 years of experience in Asia Pacific, 14 of which have been in the Medical Industry. He has specialized in the area of Value Based Healthcare, helping hospitals and laboratories quantify the financial and operational benefits of purchasing based on Total Value of Ownership (TVO).

In his role at Abbott Diagnostics, he has implemented and delivered TVO models, which have been applied in both public and private laboratory settings to become evidence based, healthcare management tools for calculating and controlling costs and delivering and quantifying value both inside the laboratory and beyond. The TVO methodology has helped healthcare institutions develop procurement models which facilitate better purchasing decisions by reducing risk and unlocking value, resulting in an overall reduction in the cost of healthcare.
Image of Jose SantiagoJose Santiago   
Global Marketing Manager for Alinity ci-series Immunoassay and Clinical Chemistry Reagents, Abbott Diagnostics 




Jose Santiago joined Abbott in 2003 as a Technical Support scientist for Immunoassays on Abbott's legacy platforms, TDx and AxSYM. Since then, he has held several roles throughout the organization, including Operations, R&D, Scientific Affairs in Latin America and Canada, and most recently, Global Marketing. Currently, Jose leads the marketing team responsible for bringing to market assays for the Alinity ci-series.

Jose received his Bachelor of Science degree in Molecular Biology Microbiology from the University of Central Florida and a Doctorate degree in Biological Sciences from Northwestern University.
Explore 


tvo-article-collaborate.jpg

Article: Total Value Ownership 

Read how three laboratories from around the world used the Total Value of Ownership methodology to help reach their goals.

Read the Article

Alinity-home-image.png

Alinity Systems

Discover how Alinity uses technology to help redefine and improve operational productivity and confidence in your laboratory.

Get to know Alinity

tvo-korea-cover-image-300x200.jpg
Case Study: Korea Clinical Laboratory 

Learn how one laboratory underwent significant change to achieve sustainable growth through Total Cost of Ownership.

Visit the Case Study

©2019 Abbott,  Abbott Park, Illinois, U.S.A.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

All ARCHITECT analyzers, Alinity hq, CELL-DYN Ruby, CELL-DYN Sapphire and CELL-DYN Emerald 22 AL instruments are Class I laser products. ACCELERATOR APS and ACCELERATOR a3600 are Class II laser products. 

The Alinity, ARCHITECT, ACCELERATOR and CELL-DYN systems are intended for performing in vitro diagnostic assays on samples of human origin (blood, urine). Read the instructions in the system manuals and labeling and/or reagent instructions carefully. Manufacturer or Authorized Representative: Abbott Germany.

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.

Do you wish to continue and exit this website?

Yes No

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

Do you wish to continue and enter this website?

Yes No

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

Do you wish to continue and enter this website?

Yes No

DO YOU WISH TO CONTINUE AND EXIT THE CORE LABORATORY WEBSITE?

Content is not under the control of corelaboratory.abbott.

Yes No